Here's What to Expect From TJX Companies' Next Earnings Report
The apparel giant is expected to announce its second-quarter results on Wednesday, Aug. 20. Ahead of the event, TJX is expected to report a non-GAAP profit of $1.01 per share, up 5.2% from $0.96 per share reported in the year-ago quarter. On a more positive note, the company has surpassed the Street's bottom-line estimates in each of the past four quarters.
More News from Barchart
Dear Microsoft Stock Fans, Mark Your Calendars for July 30
Dear QuantumScape Stock Fans, Mark Your Calendars for July 23
NVDA Broken Wing Butterfly Trade Targets A Profit Zone Between 150 and 160
Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today!
For the full fiscal 2026, analysts expect TJX's EPS to come in at $4.47, up 4.9% from $4.26 reported in fiscal 2025. In fiscal 2027, its earnings are expected to further surge 10.1% year-over-year to $4.92 per share.
TJX stock prices have gained 11.4% over the past 52 weeks, lagging behind the S&P 500 Index's ($SPX) 14.5% surge and the Consumer Discretionary Select Sector SPDR Fund's (XLY) 19.9% returns over the same time frame.
Despite beating Street expectations, TJX Companies' stock prices dropped 2.9% in the trading session following the release of its Q1 results on May 21. Driven by an increase in customer transactions, the company's comparable sales increased 3% year-over-year. This led to a 5.1% growth in net sales to $13.1 billion, beating expectations. Further, its EPS of $0.92 surpassed the consensus estimates by 2.2%.
However, due to higher SG&A expenses and cost of sales, TJX's margins suffered during the quarter. Further, operating cash flows dropped 46.5% year-over-year to $394 million, due to increased inventory levels. At the end of Q1, its merchandise inventory stood at $7.1 billion, up from $6.2 billion in the year-ago quarter. While this might be a result of TJX trying to beat tariffs, increasing inventory in apparel may lead to inventory becoming obsolete.
Nonetheless, the consensus view on TJX remains extremely optimistic, with a 'Strong Buy' rating overall. Of the 21 analysts covering the stock, 18 recommend 'Strong Buy,' one suggests 'Moderate Buy,' and two advise a 'Hold' rating. Its mean price target of $144.18 represents a 14.1% premium to current price levels.
On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Lysoway Therapeutics Awarded Grant from The Michael J. Fox Foundation to Advance TRPML1 Agonist to Treat Parkinson's Disease
CAMBRIDGE, Mass., August 06, 2025--(BUSINESS WIRE)--Lysoway Therapeutics, Inc., a biopharmaceutical company developing small molecule modulators of lysosomal ion channels, today announced that it has received a research grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF). Support comes from MJFF's Parkinson's Disease Therapeutics Pipeline Program, which focuses on candidates with strong potential to slow or halt disease progression or alleviate burdensome symptoms for those living with Parkinson's disease. Lysoway Therapeutics funding of $2.93 million will support the preclinical and translational development of Lysoway's novel, highly brain-penetrant small molecule TRPML1 agonist. The study aims to investigate whether activating TRPML1 by a novel, small molecule modulator, will enhance the lysosomal membrane calcium ion channel to restore lysosomal function and help with clearance of alpha-synuclein, the protein that is linked to the disease. "We are honored to receive this generous grant from The Michael J. Fox Foundation," said Valerie Cullen, PhD, Principal Investigator and SVP of Research and Translation at Lysoway. "TRPML1 is a high value target due to its pivotal role in sensing and responding to cellular stress. By activating this ion channel, we can engage multiple beneficial pathways that restore autophagy/lysosomal homeostasis and bolster cellular resilience. Our lead development candidate is both orally bioavailable and highly brain-penetrant, offering strong potential to modify disease progression in Parkinson's Disease." Yongchang Qiu, PhD, Founder and Chief Executive Officer of Lysoway Therapeutics, added "This funding underscores growing confidence in TRPML1 as a compelling target for Parkinson's disease. It will allow us to accelerate development of our lead TRPML1 agonist and to establish key biomarkers for target engagement, with the goal of initiating first-in-human clinical trials early next year." About Lysoway Therapeutics, in Cambridge, MA, Lysoway Therapeutics is a leader in developing therapeutically viable lysosomal ion channel modulators. The company is advancing a pipeline of small molecule activators targeting these channels to treat neurodegenerative diseases. Learn more at View source version on Contacts Media contact: Info@
Washington Post
25 minutes ago
- Washington Post
What the NFL's deal with ESPN means for the league, networks and RedZone
The NFL and ESPN have reached their long-awaited agreement that gives the Disney-owned sports network access to league media properties, including NFL Network and RedZone, while the NFL takes a 10 percent equity stake in ESPN. The two sides announced the deal Tuesday night, calling the agreement 'nonbinding.' The transactions included in the deal are 'subject to the parties' negotiation of definitive agreements, various approvals including by the NFL team owners, and customary closing conditions,' the NFL and ESPN said. The Walt Disney Company is scheduled to announce its quarterly earnings Wednesday morning.
Yahoo
an hour ago
- Yahoo
Why Over a Third of People Expected To Get Richer Over the Next Six Months — But Now See a Darker Future
Consumer sentiment is a fickle thing. Between macroeconomic factors, such as the state of the global economy, and personal finance issues, such as losing a job, Americans can rapidly change their confidence about their economic condition. Trending Now: Read More: In 2023, for example, Americans were generally positive. According to a CivicScience survey at the time, 38% expected improvement in their personal finances over the subsequent six months. But with the uncertainty over tariffs and the economy as a whole in 2025, some of that optimism has worn off. Here's a look at the factors affecting Americans' perceptions of their own financial situation and how they tend to change over time. How Do Americans Feel About Their Finances in 2025? According to Gallup, as of April 2025, Americans have decidedly soured on the economy, the stock market and their own personal finances. In fact, the Gallup data shows that a record-high 53% of Americans now believe their financial situation is actually getting worse. This is the first time since 2021 that a majority of Americans have felt pessimistic about their finances and marks a decided change from January 2025, when the majority were much more positive about the stock market and the economy. How much have opinions changed? Here's an overview of the Gallup poll results: The stock market: In January, 61% of respondents felt the stock market would go up, but in April, 58% expected the market to fall. Inflation: In January, 52% of respondents expected inflation to go up, but that percentage increased to 63% by April. Interest rates: The percentage of Americans expecting inflation to rise jumped from 52% in January to 63% in April. Check Out: Perhaps most significantly, a record high of respondents said that their financial situation is getting worse. More than half called their financial situation either fair or poor, with only 10% regarding it as excellent. Similarly, Americans' outlook for the future has soured, as well. The Gallup research shows that a record-high 53% of respondents see their financial position as getting worse, versus just 38% seeing a major improvement. How Much Do Tariffs Play a Role? It's likely more than a coincidence that Americans changed their attitudes about the economy and their finances shortly after President Donald Trump announced his 'Liberation Day' tariffs. If nothing else, the uncertainty regarding exactly what the final tariff policy will look like — and how it will affect American businesses — has diminished the confidence of the American consumer over the short run. But if the tariffs remain in place, keep inflation elevated and slow domestic growth, as predicted by the Peterson Institute for International Economics and others, it could hurt both the job market and the stock market. This is likely the concern reflected in the Gallup poll results. The Long-Term Trend Is Usually Up — With Some Caveats In spite of any short-term macroeconomic factors, Americans tend to build wealth as they age. For one thing, they have more time to save and invest, and compound interest does an amazing job at increasing net worth. This is particularly true for homeowners and those who invest in retirement plans like IRAs and 401(k) plans. For another, Americans tend to earn more money as they age and become more valuable as workers within their chosen fields. Peak earnings usually occur during their 50s and 60s. Although there are times when the average net worth of Americans decreases, such as during recessions, over the course of a lifetime, most Americans steadily increase their net worth. This is the bedrock reason why most Americans are generally optimistic about their financial futures. While there may be some short-term pain ahead for both the economy and Americans' personal financial situations, attitudes about the future will likely improve if and when the uncertainty regarding tariffs dissipates. More From GOBankingRates Mark Cuban Warns of 'Red Rural Recession' -- 4 States That Could Get Hit Hard Clever Ways To Save Money That Actually Work in 2025 Mark Cuban Tells Americans To Stock Up on Consumables as Trump's Tariffs Hit -- Here's What To Buy This article originally appeared on Why Over a Third of People Expected To Get Richer Over the Next Six Months — But Now See a Darker Future
